Sign in

CIK 0001478320

  • Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
270907024
Phone
+1 206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Planned sale President and COO sold 69,061 shares at an average $14.60 ($1,008,622)
  2. 4 Planned sale President and COO sold 57,180 shares at an average $14.45 ($826,251)
  3. 4 Planned sale President and COO sold 57,180 shares at an average $13.26 ($758,108)
  4. 4 Planned sale Chief People Officer sold 22,564 shares at $15.07 ($340,039)
  5. 4 Planned sale Chief Scientific Officer sold 10,000 shares at $14.85 ($148,500)
  6. 4 Planned sale CEO and Chairman sold 120,595 shares at an average $14.65 ($1,766,839)
  7. 4 Planned sale President and COO sold 69,061 shares at an average $14.34 ($990,503)
  8. 4 Planned sale President and COO sold 38,120 shares at an average $14.53 ($553,693)
  9. 4 Planned sale President and COO sold 57,180 shares at an average $13.14 ($751,303)
  10. 4 Planned sale President and COO sold 57,180 shares at an average $14.03 ($802,235)
  11. 4 Planned sale President and COO sold 57,180 shares at an average $13.46 ($769,643)
  12. 4 Planned sale President and COO sold 57,180 shares at an average $13.33 ($762,209)
  13. 4 Planned sale President and COO sold 179,703 shares at an average $13.21 ($2,374,058)
  14. 4 Open-market sale Director sold 15,394 shares at $13.91 ($214,131)
  15. 4 Planned sale Chief People Officer sold 30,593 shares at $14.08 ($430,749)
  16. 4 Open-market sale Chief Commercial Officer, MRD sold 41,338 shares at $13.17 ($544,421)
  17. 4 Open-market sale Chief Commercial Ofc Imm Med sold 63,103 shares at $13.17 ($831,067)
  18. 4 Open-market sale Chief Financial Officer sold 18,672 shares at $13.17 ($245,910)
  19. 4 Open-market sale Chief Scientific Officer sold 470,266 shares at $13.17 ($6,193,403)
  20. 4 Open-market sale CEO and Chairman sold 470,167 shares at $13.17 ($6,192,099)

Page 3 of 28 · 544 filings